Assura Limited (AGR) Earnings Call Transcript & Summary

July 6, 2022

London Stock Exchange GB Real Estate shareholder_meeting 28 min

Earnings Call Speaker Segments

Operator

operator
#1

Good morning, ladies and gentlemen, and welcome to the Assura Plc Annual General Meeting. Throughout this recorded meeting attendees online will be in listen only mode. Questions are encouraged and can be submitted at any time using the Q&A tab situated on the right hand corner on your screen. Just please simply type in your questions at any time and press send. The company may not be in a position to answer every question submitted today. However, all questions will be reviewed with the responses published on the Investor Meet Company platform. I'd now like to hand over to Chairman, Ed Smith. Good morning, sir.

John Edward Smith

executive
#2

Good morning. Thank you very much. Good morning, everyone, and it is -- it has been said now 11 O'Clock and there is a quorum present, and it's pretty nice to have all shareholders present with us in the room this morning as well as those viewing live by the Investor Meet platform. Investors watching the meeting via this platform are able to see and hear the AGM, but are not seen or heard by the Board and as made clear in the notice of the AGM are unable to vote via that platform. Questions may be submitted in writing over the platform and will be addressed at relevant points during the AGM. I'm joined here today by all of my fellow directors, and I'll just briefly introduce them to you before we begin. Company Secretary, [indiscernible] to my left, Louise Fowler, Jonathan Davies, Jayne Cottam, Jonathan Murphy, Noel Gordon, all of our shareholders, Laura [indiscernible], who is a board fellow under a board fellowship program, we are jointly investing in, Sam Barrell and Emma Cariaga. Jonathan, you'll now provide us with a brief overview of the first quarter results, which were announced this morning.

Jonathan Murphy

executive
#3

Yes. Thanks, Ed, and good morning, everyone, and I'm glad to welcome you all today to the AGM. So I'm sure you all have seen the announcement this morning, very pleased to say that we've had a very strong first quarter to the year. We're very pleased with the way we ended last year. We had a very strong performance last year in terms of outperforming the market's expectations in terms of earnings and also from a net asset value point of view. And we were delighted with the progress we made on -- particularly on the financing side last year. So we completed our sustainability bond this time last year as well as an equity raise towards the back end of October, which means that we entered the new financial year very well capitalized and in a very strong position. I'm pleased to say that we've then been able to continue to deliver on our growth plans, continuing to complete both acquisitions and developments, and in excess of GBP 100 million invested in the first quarter, which is a very strong start to the year. We are also seeing our developments moving forward. So we've had 2 developments completed in the first quarter, and we're starting on site with a further 2 sites. Now we are moving slightly cautiously with our developments. So I'm sure you all will have read in the papers about construction cost inflation, supply chain disruption, and it's fair to say that we are experiencing some delays on some of our projects. So we are adopting a cautious approach and only moving forward with schemes once we've got certainty on pricing, we've got fixed price contracts in place and we're certain that we've got the right partner, and we've got all the commercials lined up with the NHS for pressing ahead. So we might be slightly slower than anticipated in terms of development, but we still got a very strong pipeline of opportunities. I mean ultimately, the NHS remains in a position where it has a very strong requirement for further investment in the types of assets that we produce. That hasn't changed given the economic circumstances, so we anticipate that there will continue to be further projects and further opportunities for us to invest over the coming months and for the rest of the year. Though we will be adopting a disciplined approach and only pursuing those opportunities that we feel will provide a real turn in the current environment. In terms of available facilities, as I mentioned, we did a bond last year. We did our equity raise. So we're very well capitalized and we had available cash and undrawn facilities of in excess of GBP 226 million at the end of June. So we have the available resources to continue to deliver on the opportunities that we see in front of us. And our debt book is incredibly strongly positioned over 7 years of maturity. Everything is fixed. So we've got no exposure to short-term interest rates. So overall, on balance, very pleased with the progress to the financial year, and we continue to see good opportunities moving forward.

John Edward Smith

executive
#4

Thank you, Jonathan. Now there's an opportunity for any questions that would come in online or also any questions that our shareholders would like to ask about the company performance and our staff by asking colleagues who've joined us -- shareholders who joined us in the room. If you'd like to give your name, please.

Unknown Shareholder

shareholder
#5

[indiscernible]. What's the size of the projects you're getting [indiscernible]?

John Edward Smith

executive
#6

So yes, so the size of a -- relatively small project. So the average size of our development will be GBP 7 million or GBP 8 million at that type -- that type of size. So not sort of GBP 100 million hospitals. There are some projects which are a little bit bigger. So you might have read in our results presentation, we talked about, we've done just on Newtown in Birmingham, which is an ambulance hub. So -- and that project is in excess of GBP 20 million. We've got a project up in the Northeast, which is just under GBP 20 million. So those are a bit bigger. So we do a range, but those are sort of -- that's the upper limit really. So no, we're not building large-scale hospitals, it's community health facilities, whether that's directly occupied by GPs or supporting the NHS [indiscernible]. So, that's the size.

Unknown Shareholder

shareholder
#7

Do you get involved with partners at all in bigger project?

John Edward Smith

executive
#8

Yes, absolutely. So a really good example of that ambulance hub that I mentioned. That's the first time we've done an ambulance hub. So we didn't build that ourselves. We went into partnership with a company that had experience in that area. Though interesting what we've done is we've learned from that project and we're now bidding on a second project where actually we will lead and we'll learn from that and take the lead on the next one. So you're absolutely right. If it's slightly outside of our core, we would look for a partner to work with.

Unknown Shareholder

shareholder
#9

[ BG ] a big hospital project actually the results...

John Edward Smith

executive
#10

That's a different scale to us. And one of the good things about the type of projects we work on is we've got 18 projects. So they're all relatively modest in size. So you don't have all your 18 [indiscernible]. So you've got 18 different contractors because obviously, contractor failure is a risk that you could face. So we're well diversified, well spread out, and they're relatively modest projects.

Unknown Shareholder

shareholder
#11

We've got -- and what percentage of your rents are inflation rents and what's the inflation cap?

John Edward Smith

executive
#12

Very good question. Yes. So in terms of our -- in terms of the rent, we always split. So 65% of our leases are under open market reviews. So that's effectively negotiated with the NHS and there's no cap or color on those, but it's what you negotiate with the NHS last year that they delivered growth of 1.4%. So they have an indirect linkage to construction cost inflation, and it's -- that's a commercial negotiation, that's 65%. Then you have 15% of the portfolio, which is uncapped RPI direct with the NHS. So that's the RPI. So this year, that will be 12% is I think the most recent estimate. So that's 15% of the portfolio. We then have another 6%, which is RPI, but has a cap. And typically, everyone is different but about 4% is the normal cap. And then we have the last 14%, which is a fixed uplift or other metrics. So 2% over every year or steps or whatever. So you've got the overall shape of 65% open market. So 21% RPI of which 15% is uncapped, and then you've got the 14%, which is fixed on this. So it's not a complete index linked portfolio, but it's got very strong characteristics.

Unknown Shareholder

shareholder
#13

The [ side ] I was going to ask for that is are any of your borrowing inflation index or a fixed rate, in which case, presumably the company in a very good position because it's getting inflation linked uplifts on its premises and this is fixed rate borrowing?

Jonathan Murphy

executive
#14

To explain a little bit more about the debt book and how it's set up for me?

Jayne Cottam

executive
#15

Yes. So as the trend notes, all of our debt is fixed our maturity is now 7.7 years. And you're absolutely right. We did our sustainability bond last year, 1.625%, GBP 300 million with a 12-year maturity. But the year before, we did a social bond, 10-year money at 1.5%. So all of our longer-dated debt is at a much lower fixed rate. So everything we have is fixed, there is nothing variable that's strong. At the moment, and our weighted average interest rate has actually come down to 2.3%. So you're right, we're very well positioned. We've got cash in some available facilities, GBP 266 million to manage all our ambitious plans going forward.

Unknown Shareholder

shareholder
#16

And if I may just know supplement in terms of health service organization. What sort of confidence do we have in the event that practices emerge and then a practice on closed out?

Jonathan Murphy

executive
#17

Yes. So in terms of -- if you got -- there are 2 ways that we have, we have 82% of the rental, which is linked to the NHS. And there are 2 ways that can be done. One is some direct with the NHS. And then the other way is via the GPs. So if we've got a lease with a GP practice and they have a GMS contract, then the GPs have a statutory right to have that reimbursed. So as long as they are operating, that's that contract from that location, then you could effectively you've got an NHS guarantee. Now in the event that they closed that practice and discontinue that GMS contract, then effectively, the doctors would be transferring that liability from the NHS to themselves. So if this has happened to us in 1 case, and in that situation, the partners closed their contract and effectively transferred a liability to about GBP 160,000 from the NHS to themselves. Now as soon as they realized that's what they've done from [indiscernible] that wasn't the course of action they wanted to go down, and they had a different conversation with the NHS. And actually, what happened in that scenario was they said, we do want to retire, we want to step back rather than working out the door and triggering a liability, they had a conversation, they agreed a plan and the NHS took over the lease of that building, and they became employees of GPs. And then over a number of years, they've subsequently gone on to retirement. So there'll be a managed process. If there isn't a managed process the GPs end up exposed, which is why there's that one pace and they've attracted. So we've never actually seen that situation. But we're constantly having conversations with our occupiers to understand what their outlook is -- and if they have any concerns, we encourage them to talk to the NHS. So because the system absolutely wants that center to stay occupied and stay providing services to those patients. Even if the individual doctors might be coming up to retirement [ they might want to leave ].

Unknown Shareholder

shareholder
#18

The current pension arrangements are forced promoting early retirement.

John Edward Smith

executive
#19

It's really unhelpful. It's really unhelpful. It's actually just as bad in hospitals as well. So essentially, yes, as you reach the upper limit of your pension cap, effectively to stay and work another year you can get a really cumulative tax bill. And it's encouraging GPs to retire early, it's -- yes. It's slightly broader agenda.

Unknown Shareholder

shareholder
#20

But it's really longer anyway.

John Edward Smith

executive
#21

Perhaps not the best pension policies I would say. I'll leave it at that.

Jonathan Murphy

executive
#22

Jayne, you will have some questions sort of come through on the.

Jayne Cottam

executive
#23

Yes. I've joined...

Jonathan Murphy

executive
#24

So in terms of the pre-submitted questions, we've got a question from Alessandro, which is saying. What is the raise on debtor of the company? Gosh, that's a philosophical one. And where do you draw the line between shareholder and stakeholder interest. So what's the raise on debt of the company? So we have an overall mission, which is we build for health, which is about providing the right facilities to support the NHS in delivering successful health outcomes and reducing health in the quality. So that's the overall objective. But obviously, in that, we have multiple stakeholders. We have shareholders, and we provide a 4.7% dividend yield that we've been growing at 5% a year, and that's obviously absolutely essential. We have banks that we have to raise money from and bondholders that we have to provide returns, and we have an investment-grade rating for that. We obviously have our team who is a key stakeholder. We have to make sure that we look after because can't do anything without the team supporting us. And of course, we have a commitment and an obligation to support the environment and to do what we can to support sustainability. So there isn't one. It's the short answer. I was under -- it's a mixed model. We look -- we have all stakeholder interest at heart. I mean clearly, the financial returns is a key priority for us. But then so is sustainability and making sure that we deliver that. You can't do one without the other. We can't deliver positive health outcomes if we don't give good financial returns because we need the support from investors and banks to be able to fund that. So it's not mutually exclusive, it's mutually supported. So further question from Alessandro is -- is there an optimal size for the company, either by number of assets or financially. So it's a really good question. So over the last 5 years, we have effectively doubled the size of the business. So we've got now almost a GBP 3 billion, GBP 3 billion portfolio. And as part of that process, by becoming larger, we've been able to access the bond market, for example, so because we can now afford to raise GBP 300 million in loans over the bond, we can get better interest rates because it's a deeper, more liquid market. So scale gives you certain advantages in terms of capital markets. So you can raise equity more efficiently, you can raise bonds more efficiently. So that's an advantage. There's definitely an advantage in terms of efficiency. So we have a certain amount of overhead. We have certain amount of corporate overhead. And obviously, if you have a larger portfolio, you can spread that over your fixed costs over a larger base. So we have brought -- over the last 8 years, we brought our cost ratio down 20% of our income to about 13%. So clearly, again, you can see there's an economy of scale. So there are economies of scale. Is there an optimal size? Well, no, there isn't really. So benefits from being slightly larger. But equally, we don't chase size or just for its own reward, it's about whether it provides the right overall return. So we're very comfortable with the size we have. We have delivered economies of scale, but there isn't really a target or outsized equally very comfortable if we continue to grow, but equally will be very comfortable at the current size of the business. So I hope that helps, Alessandro. So further question we've had online is from Nick. It is what are your views on adding social prescribing facilities to your offering, which could include gym, sport, gardening, Tai chi, green space -- making use of green space. Really good question, Nick. It's actually a question we got asked by shareholder at our AGM about 7 years ago, which was really interesting because then I remember very well because at that time, social prescribing wasn't really something that people were talking about and he was involved with a charity that was providing those types of activities and supporting the local GP, but it's the first time I've really heard of that. It's now something that we really actively support. We provide -- we have our Assura Community Fund, which supports health and wellness activities lead to our buildings as social subscribing is a really important part of that. That could be a garden for providing -- communal garden for people to come and socialize and use the garden, it could be supporting walking groups. It could be providing an ability to get debt advice, for example, might sound very non-health related, but actually worrying about finance. It actually can have a material impact on your well-being and your health. So all of those things, absolutely. We do that either through our own -- through the green spaces, through our project to the community fund or working with the GPs. So it's a really, really good question because it's a really important part of what we do. And a question from Andrew, which I'll ask Jayne to answer, which is what percentage of your borrowing is fixed versus variable. It's quite an easy one.

Jayne Cottam

executive
#25

Yes. So Andrew, all of our debt is fixed, 2.3% average interest rate. We have no variable rate borrowing at this time.

Jonathan Murphy

executive
#26

That's the last of the questions that we've had submitted online.

Unknown Executive

executive
#27

I'm just hoping -- you don't have a planning problem by any transfer [indiscernible] premises.

Jonathan Murphy

executive
#28

Yes, just one thing, not giving much information from my acting I presume on your voting is, there'll be share buybacks for that seem be automatic in it. That is a bit of a bet from share buybacks. You're a growth company. So I hope you don't ever get driven down that road sort of [indiscernible]. You see this is in trouble. And the other thing is you have [indiscernible] Smart City bankers come on to, or sale and leaseback and lend yourselves down with some debt. You can fund us with dividend. So I mean you're a growth company, don't waste your money, share buyback because do you expect to you're going to need to finance -- there's no still anything we finance a to GBP 300 million going by some shares.

John Edward Smith

executive
#29

Well, I mean, Jonathan, you've got to -- if you wanted to do that, you have to time it right, et cetera. We do have a general provision to give us flexibility on how we deal with our [indiscernible]. So, yes, there's a question on the AGM, which is asking for authority. I can assure you, we have no plans to venture into any share buyback. We have plenty of opportunities to deploy that capital into health facilities and new projects with the idea of buying shares, it's not on the agenda.

Unknown Executive

executive
#30

It just means to get this to we don't know what to do with that money. You have to...

John Edward Smith

executive
#31

I think we have...

Unknown Executive

executive
#32

You can pay big dividends and then I also -- so I don't pay the tax [indiscernible].

John Edward Smith

executive
#33

That's currently not a problem we think to have not say that [indiscernible]. It's not a plan of ours.

Unknown Executive

executive
#34

No, I think it's a different view between institutions and private shareholders. We know who wins in that battle, there we are. You say you have limited information through your [indiscernible] shareholding, although the website has it, if you [indiscernible] set of accounts please do because I can easily get another one and it's an excellent [indiscernible].

Unknown Executive

executive
#35

I love a block of flats with [indiscernible].

John Edward Smith

executive
#36

Enjoy reading that, which is an excellent read and we'll see you next year and answer questions on the annual [ meeting ]. Okay. So thank you very much. We'll now proceed with the formal business of the AGM, which consists of the 18 resolutions, which are set out in the notice of meeting dated the 1st of June, and which was sent to you together with an explanatory note, and the annual report itself. As mentioned in the circular and as committed under the Articles of Association, I direct that all business to be transacted at today's AGM be voted on by way of a poll. This will result in a more accurate reflection of the views of shareholders by ensuring that every vote is recognized, including the votes of those shareholders who are unable to attend physically, but who have been a [indiscernible] appointed proxies for the meeting. Shareholders present in person, corporate representatives and proxies are, of course, entitled to vote. The notice of the meeting includes no less than 18 items of business for your consideration. An explanation of each of these is set out in the AGM circular. But in summary, Resolution 1 covers the annual report and accounts for the year ended 31st of March 2022. Resolution 2 seeks approval of the directors' remuneration policy for the year ended 31st of March 2022 contained in the annual report and accounts, which so you can read at your leisure. Resolution 3 seeks approval by way of advisory resolution of the directors' remuneration report for the year ended 31st of March 2022 contained in the annual report and accounts. Resolutions 4 and 5 are our audit-related resolutions. Resolution 6 to 13 cover the reelection of Louise Fowler, Jonathan Murphy, Jayne Cottam, Jonathan Davies, Sam Barrell, Emma Cariaga, Noel Gordon and myself as directors. And Resolutions 14 to 18 cover capital and other issues, including authorizations relating to the allotment of share capital and the disapplication of preemption rights, the repurchase of shares and the notice period for general meetings. Resolutions 15 to 18 are proposed as special resolutions. Does anyone have any questions on any of today's resolutions before we proceed to voting.

Jonathan Murphy

executive
#37

Nothing online.

John Edward Smith

executive
#38

I can explain the voting procedure, but I've mentioned now the fact because all resolutions will be voted on by way of a poll. These resolutions will be in effect voted on simultaneously rather than sequentially. Accordingly, this is one opportunity for you to ask any questions you might have before I ask you to vote. The process, Company Secretary, Fowler will act as scrutineer in connection with the poll. She will be assisted by our registrars, Link Asset Services. Only shareholders or their proxies or corporate representatives are entitled to vote on the poll. To vote on the poll, you will need a poll card, which you have given up on registration. If you wish to vote on the poll in more than 1 capacity, you will need a separate poll card for each capacity in which you wish to vote. And if you need a further poll card, please put your hand up now. Obviously, any colleagues who are physically present and one will be passed to you. The shareholders present who have returned the form of proxy need not to complete the poll card unless they wish to alter their voting instructions of now. However, if a shareholder completes a poll card now, any proxy vote that has already been given that will be canceled. When the poll procedure commences, you should insert your name in the poll card in the places indicated for name of the shareholder. If you're using the poll card to vote on only some of the shares registered that you have to insert the number of shares and put across in respect of each resolution to indicate you're voting for or against that resolution. You should then sign a card in the place indicated and the cards will be collected after you have completed. Does anybody have any questions on the voting? Sorry, I have to go through that for obvious reasons. And I know given that the number of AGMs have not taken place physically and over the last couple of years, it's worth reminding everybody. So we can now commence the poll of you all submitted the 4 of you submitted as necessary -- would you like to hand the [indiscernible]. Thank you very much. Thank you very much. So as there are no more poll cards to be completed, the poll is now closed, and the results of the poll on each resolution will be determined by all the board as scrutineer. This will take some time. The results will be announced by an RNS as soon as practical, and we expect it to be honest, to be later today as we have significant proxies votes lodged at the relevant proxy cutoff time. And these are also available to -- from what I should anybody wish to see. So that concludes the AGM. And -- we thank all of our shareholders, Jonathan, rightly said, we are very focused on shareholder value. But in doing -- in providing shareholder value, we are also conscious of our wider stakeholder obligations and community in the virtuous circle that is created by driving being a really great organization to do business with and the delivery of that shareholder value. And we thank you for your support as shareholders in that endeavor. And with that, thank you for attending the AGM and I call the meeting closed. Thank you very much indeed.

Operator

operator
#39

That's great. Thank you Very much indeed. Could I please ask attendees online, not to close the session as we'll now automatically redirect you to the opportunity to provide your feedback in order that the Board can better understand your views and expectations. This will only take a few moments to complete, but I'm sure it'll be greatly valued by the company. On behalf of the Board of Assura Plc, we'd like to thank you for attending annual -- today's Annual General Meeting online and may I wish you all a very pleasant morning. Thank you.

John Edward Smith

executive
#40

Thank you very much.

Jonathan Murphy

executive
#41

Thank you.

Unknown Executive

executive
#42

Thank you so much.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Assura Limited transcript — plus 256,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Assura Limited earnings transcripts and 256,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.